Cervicitis Treatment

Die Behandlung der Zervizitis richtet sich nach Ursache, Verlauf und individueller Symptomatik. Während akute, infektiöse Formen primär mit Antibiotika oder antiviralen Medikamenten behandelt werden, stehen bei chronischen oder hormonell bedingten Zervizitiden regenerierende Maßnahmen im Vordergrund. Besonders bei postmenopausalen Frauen oder Patientinnen ohne nachweisbaren Erreger hat sich die Lokaltherapie mit Vaginalzäpfchen bewährt. CANNEFF® VAG SUP Zäpfchen mit CBD und Hyaluronsäure wirken entzündungshemmend, feuchtigkeitsspendend und fördern gezielt die Schleimhautheilung – eine effektive Ergänzung oder Alternative zur systemischen Therapie. Die Behandlungsdauer variiert je nach Ursache von wenigen Tagen bis zu mehreren Wochen. Rückfälle treten häufig auf und erfordern eine umfassende Nachsorge inklusive Partnerdiagnostik, Schleimhautpflege und ggf. Milieustabilisierung. Bei sexuell übertragbaren Infektionen ist die Mitbehandlung des Partners essenziell. Die Kombination aus Erregerelimination, Schleimhautregeneration und Hygienemaßnahmen ermöglicht eine nachhaltige Kontrolle der Erkrankung und schützt vor Spätfolgen wie aufsteigenden Infektionen oder Fertilitätsstörungen.
Philip Schmiedhofer, MSc

Autor

Philip Schmiedhofer, MSc

Inhaltsverzeichnis

Which therapies are suitable for cervicitis?

The treatment of cervicitis depends on the cause, the course (acute or chronic), and the individual circumstances (e.g., pregnancy, menopause, recurrent infections).

When is antibiotic therapy necessary?

Antibiotic therapy is always necessary when bacterial cervicitis is present.

Antiviral medications for viral cervicitis

Viral cervicitis typically occurs due to an infection with certain viruses that inflame the mucous membrane of the cervix.

How long does the treatment take?

The duration of treatment for cervicitis depends significantly on the cause, the course of the disease (acute or chronic), the type of pathogen, and the individual response to therapy.

Local therapy vs. systemic therapy – which is better?

The decision between local or systemic therapy for cervicitis depends on the origin of the inflammation, the course of the disease (acute vs. chronic), and the general health condition of the patient.

Suppositories for Cervicitis – Benefits and Usage

Vaginal suppositories are a proven form of local therapy for cervicitis. They act specifically on the inflamed mucous membrane of the cervix without burdening the entire body.

CANNEFF® Vaginal Suppositories: Support for Mucous Membrane Healing

CANNEFF® VAG SUP vaginal suppositories were specially developed to regenerate the vaginal and cervical mucosa in cases of inflammatory, irritative, and hormonally induced complaints.

What to do in case of relapses?

Relapses in cervicitis – especially in the chronic or recurrent form – are not uncommon and pose a particular challenge in gynecological practice.

When is a partner treatment necessary?

Partner treatment is a central aspect in the therapy of infectious cervicitis, especially in sexually transmitted infections (STIs).

What should be considered after the treatment?

After treating cervicitis, it is important to ensure the complete healing of the mucous membrane and to prevent relapses.

Which therapies are suitable for cervicitis?

The therapy of cervicitis depends on the cause, the course (acute or chronic), and individual circumstances (e.g., pregnancy, menopause, recurrent infections). The goal is targeted treatment of the trigger, calming the mucosa, and restoring a stable vaginal environment.

Treatment of cervicitis

Infectious cervicitis usually requires specific anti-infective therapy; non-infectious or hormonally caused forms benefit from regenerative and caring local therapies.

Therapy pillar

Objective

Examples

Antibiotics

Eradication of bacterial pathogens

Doxycycline, azithromycin, ceftriaxone

Antimycotics

Treatment of yeast infections

Clotrimazole, fluconazole

Antivirals

Control of viral infections (e.g., HSV)

Acyclovir, Valacyclovir

Local therapy (suppositories)

Mucosal care and regeneration

CANNEFF® VAG SUP with CBD + hyaluronic acid

pH value regulation

Stabilization of the acidic vaginal environment

Lactic acid suppositories

Probiotics (oral or vaginal)

Rebuilding the physiological flora

Lactobacillus preparations

Hormonal local therapy

Regeneration of atrophic mucosa

Estriol creams or suppositories (if indicated)

Phytotherapy (complementary)

Anti-inflammatory, soothing

Chamomile, witch hazel, myrrh

When is local treatment sufficient?

In non-infectious, hormonally caused, or post-infectious cervicitis, local treatment alone can be useful. Suppositories with regenerative properties – like CANNEFF® VAG SUP – promote mucosal healing, reduce irritation symptoms such as burning or dryness, and simultaneously have anti-inflammatory effects. Especially during menopause, this therapy offers a hormone-free and well-tolerated alternative.

Combination therapies possible

In chronic or recurring cases, the combination of anti-infective treatment and local mucosal care can be crucial to achieve complete healing and prevent relapses. Partner treatments and hygienic measures should also be considered in sexually transmitted causes.

When is antibiotic therapy necessary?

Antibiotic therapy is always necessary when a bacterial cervicitis This often involves a sexually transmitted infection, especially with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium or more rarely Ureaplasma urealyticum. Also mixed infections with Gardnerella vaginalis (bacterial vaginosis) can cause cervicitis and may require antibiotic treatment.

Early antibiotic therapy is important to prevent ascending infection to prevent spread into the uterine cavity and fallopian tubes. Otherwise, there is a risk of Pelvic Inflammatory Disease (PID) with risk of infertility.

Indications for antibiotic therapy

  • Positive pathogen detection in the swab (PCR or culture)
  • Typical symptoms with justified suspicion, e.g., purulent discharge, contact bleeding, lower abdominal pain
  • Partner infection with chlamydia or gonococci
  • Pregnancy with positive bacterial detection – even in asymptomatic cases

Commonly used antibiotics

Pathogen

Recommended therapy

Chlamydia trachomatis

Doxycycline 100 mg 2×/day for 7 days or azithromycin 1 g as a single dose

Neisseria gonorrhoeae

Ceftriaxone 500 mg i.m. + azithromycin 1 g oral

Mycoplasma genitalium

Doxycycline followed by azithromycin or moxifloxacin

Gardnerella vaginalis

Metronidazole 500 mg 2×/day for 7 days

Important: The choice of antibiotic depends on the pathogen spectrum and resistance profile – especially with gonococci, resistance is common.

Special considerations in partner treatment

For sexually transmitted pathogens such as chlamydia or gonococci, the sexual partner(s) are always treated as well are treated even if no symptoms are present. Only in this way can reinfection be avoided.

What to do if no pathogens are detectable?

If no pathogen is found despite symptoms, empirical antibiotic administration not always advisable. In these cases, it should first be clarified whether it is a:

  • non-infectious irritation (e.g., due to IUD, intimate hygiene)
  • hormonal mucosal atrophy
  • chronic post-infectious irritation conditions

is concerned.

Cervicitis treatment medications

Antiviral medications for viral cervicitis

Viral cervicitis typically arises from an infection with certain viruses that inflame the mucous membrane of the cervix. The most common viral causes include:

  • Herpes simplex virus type 2 (HSV-2)
  • Human papillomavirus (HPV)

These two virus groups require different diagnostic and therapeutic approaches, with antiviral medications primarily used for Herpes infections to be used. In HPV, the focus is instead on monitoring the course and cytological surveillance.

When is antiviral therapy necessary?

Antiviral therapy is generally used only for active herpes infections (HSV-2) used with typical symptoms:

  • pain in the genital area
  • blistering or ulcerations on the cervix
  • pronounced signs of inflammation of the cervix
  • possible contact bleeding

Antiviral treatment during pregnancy is especially important to prevent perinatal transmission to the newborn.

Medications and dosage for HSV-related cervicitis

Active ingredient

Standard dosage

Duration

Acyclovir

400 mg 3× daily oral

5–10 days

Valacyclovir

500 mg 2× daily oral

5–10 days

Famciclovir

250 mg 3× daily oral

5–10 days

In case of recurrent course can be a Long-term therapy over several months may be necessary, e.g., acyclovir 400 mg 2× daily for 6 months for relapse prevention.

What should be considered with HPV-related cervicitis?

HPV infections often do not cause acute inflammation but lead to chronic cellular changes (dysplasias) on the cervix. There is no antiviral therapy for this. Instead, the following is done:

  • regular Pap checks (cytology)
  • HPV testing
  • possibly colposcopy and biopsy
  • in high-grade dysplasia: surgical therapy (e.g., conization)

However, HPV can make more sensitive to additional inflammatory stimuli, so that a secondary, non-infectious cervicitis occurs.

How long does the treatment last?

The duration of treatment for cervicitis depends significantly on the Causethe course of the disease (acute or chronic), the pathogen type as well as the individual Response to therapy While acute, uncomplicated forms can usually be successfully treated within a few days, therapy for chronic or recurrent courses requires significantly more time and patience.

Average treatment duration by cause

Cause / form of cervicitis

Type of therapy

Duration of treatment

Bacterial cervicitis

Antibiotics (e.g., doxycycline, azithromycin)

7–10 days (single dose possible)

Gonorrhea-related

Ceftriaxone + Azithromycin

Single injection + 1 day

Trichomonads

Oral metronidazole

5–7 days

Candida-associated

Local antifungals

3–6 days

Herpes cervicitis (HSV-2)

Antiviral therapy (acyclovir, etc.)

5–10 days (possibly longer with recurrences)

HPV-associated changes

Course monitoring (Pap test, colposcopy)

Months to years, depending on the course

Chronic cervicitis

Local mucous membrane care, avoidance of irritation

4–6 weeks, possibly repeated cycles

Acute vs. chronic courses

  • Acute cervicitis usually heals within 1 to 2 weeks if therapy is started early and targeted.
  • Chronic cervicitis requires significantly longer treatment periods. Often, a multi-week regeneration therapy is necessary – especially with mucous membrane damage, hormonal atrophy, or therapy-resistant symptoms.

Mucous membrane regeneration after infection

Regardless of the pathogen type, the mucous membrane can be affected after having had cervicitis inflammatorily altered, irritated, or atrophic remain. In these cases, a subsequent convalescence phase, e.g. with:

  • Local moisture and regeneration therapy
  • Probiotic stabilization of the vaginal environment
  • Hormone-free mucous membrane care

CANNEFF® VAG SUP suppositories have proven particularly effective in this phase:

  • Application: 1 suppository daily before bedtime for 20–30 days
  • Ideal for Support of healing, Relief of irritation conditions and Prevention of relapses

Local therapy vs. systemic therapy – which is better?

The decision between a local or systemic therapy in cervicitis depends on the origin of the inflammationthe Disease course (acute vs. chronic) as well as the general health condition of the patientBoth approaches have their justification – often patients benefit from a combination of both treatment forms.

  • Systemic therapy: Active ingredients are distributed through the bloodstream, e.g., by tablets, injections. They act throughout the body.
  • Local therapy: Preparations act directly at the site of inflammation, e.g., through suppositories, creams, rinses – preferred for genital complaints.

Criterion

local therapy

systemic therapy

site of action

directly at the cervix/vagina

entire body (via bloodstream)

typical applications

suppositories, creams, rinses

tablets, capsules, injections

Goal

regeneration, moisture, protection of the environment

systemically combat infectious pathogens

Side effects

low, locally limited

possible systemic side effects

Applications

chronic cervicitis, mucosal atrophy

acute bacterial or viral cervicitis

Examples

CANNEFF® VAG SUP, lactic acid suppositories

doxycycline, azithromycin, aciclovir

When is local therapy appropriate?

  • In case of non-infectious cervicitis (e.g., hormonally induced, mechanically irritated)
  • In the Postmenopause in mucosal atrophy
  • As care after antibiotic therapyto support mucosal regeneration
  • In case of recurring irritation conditions, burning, dryness or dyspareunia
  • CANNEFF® vaginal suppositories combine CBD with hyaluronic acid and act locally anti-inflammatory, moisturizing, and healing-promoting – ideal for chronic mucosal irritation.

When is systemic therapy necessary?

  • In case of confirmed infection with bacterial or viral pathogens (e.g., chlamydia, gonorrhea, herpes)
  • When the inflammation does not respond to local measures
  • In case of ascending infection or suspicion of involvement of internal genital organs (e.g., PID)
  • In case of systemic accompanying symptoms such as fever, severe lower abdominal pain

Cervicitis treatment suppositories

Suppositories for cervicitis – benefits and application

Vaginal suppositories are a proven form of local therapy for cervicitis. They act specifically on the inflamed mucous membrane of the cervix without burdening the entire body. Especially in chronic, non-infectious, or hormonally induced forms of cervicitis, suppositories have established themselves as an effective and well-tolerated option.

Advantages of vaginal suppositories for cervicitis

  • Direct effect at the site of inflammation: The active ingredients are released where they are needed – on the mucosa of the vagina and cervix.
  • Rapid symptom relief: Suppositories can quickly relieve symptoms such as burning, dryness, or discharge.
  • Gentle and locally limited: Unlike systemic therapies, hardly any side effects occur because the active ingredient barely enters the bloodstream.
  • Promoting mucosal healing: Many suppositories contain regenerative, moisturizing, or anti-inflammatory ingredients.
  • Ideal therapy for hormonal changes: Especially in postmenopause, when the mucosa is atrophic, suppositories show good effectiveness.

Application

The suppository is inserted deep into the vagina in the evening before going to bed.

  • Body heat melts the suppository, releasing the active ingredient.
  • It is recommended to remain upright after application (ideally lying down).
  • The therapy duration depends on the preparation and symptoms and is about 7 to 30 days.

Areas of application

After infections: for mucosal regeneration

Example: CANNEFF® Vaginal Suppositories

These suppositories contain cannabidiol (CBD) and hyaluronic acid – a combination with strong regenerative, moisturizing, and anti-inflammatory effects. They are especially suitable for chronic cervicitis, mucosal atrophy, and complaints during menopause. The application is straightforward, and the effect has been clinically confirmed in studies.

CANNEFF® Vaginal Suppositories: Support for Mucosal Healing

CANNEFF® VAG SUP Vaginal Suppositories were specially developed to regenerate the vaginal and cervical mucosa in cases of inflammatory, irritative, and hormonally induced complaints. They combine two medically relevant ingredients: cannabidiol (CBD) and hyaluronic acid in a patented emulsion matrix that guarantees the release of the active ingredients. This combination enables targeted, hormone-free, and well-tolerated support for cervicitis – especially in chronic or postmenopausal cases.

Mechanisms of action

  • CANNEFF® VAG SUP provides intensive moisture, improves mucosal elasticity, and supports the natural healing process in microtears and irritations.
  • CANNEFF® VAG SUP acts anti-inflammatory, antioxidant, and pain-relieving. It soothes the sensitive tissue, reduces irritation, and helps restore a balanced environment.

Areas of use in cervicitis

  • Chronic cervicitis, especially with mucosal atrophy
  • Irritative conditions without acute pathogen detection
  • Adjunct therapy after antibiotic treatment, to stabilize the mucosa
  • Postmenopausal complaints, such as dryness, itching, or contact bleeding

Usage recommendation

  • 1 suppository daily, preferably in the evening before going to bed
  • Duration of use: At least 20–30 days, can be repeated as maintenance therapy depending on clinical assessment
  • No additional applicator needed – the suppository is inserted deep into the vagina with clean hands

Advantages at a glance

  • Hormone-free and without known systemic side effects
  • No impairment of the natural microbiome
  • Clinically proven effectiveness, also for menopausal symptoms
  • Also suitable for long-term mucosal care.

CANNEFF® Vaginal Suppositories are an effective, scientifically proven, and low side-effect option to support mucosal healing in cervicitis. They are ideal as a complementary or sole measure in chronic courses, hormonally induced dryness, or irritative complaints in the intimate area.

What to do in case of relapses?

Relapses in cervicitis – especially in the chronic or recurrent form – are not uncommon and pose a special challenge in gynecological practice. Crucial for successful treatment is not only acute symptom control but also consistent follow-up care and prevention of new inflammation flare-ups.

Cause analysis

Before any renewed therapy, it should be checked why the relapse occurred. Possible reasons are:

  • Incomplete pathogen elimination (e.g., persistent chlamydia)
  • Biofilm formation that bypasses standard antibiotics
  • Reinfection by untreated partner
  • Mucosal damage due to hormonal deficits or mechanical irritation
  • Imbalance of vaginal flora (dysbiosis)

Repeat diagnostics

A comprehensive re-evaluation should be done with every relapse:

  • Cervical smear with microbiological examination (including PCR)
  • HPV test in chronic inflammation
  • If necessary, colposcopy for cervical cell changes
  • Examination of the partner, especially if STI is suspected

Long-term strategies for relapse prevention

Measure

Goal

Consistent partner treatment

Avoidance of reinfections

CANNEFF® vaginal suppositories

Mucosal care, inflammation reduction, microbiome stabilization

Probiotic therapy (oral/vaginal)

Restoration of lactobacillus flora

Hormonal local therapy

Rebuilding atrophic mucous membranes (if indicated)

Avoidance of irritating influences

No intimate douching, use of non-irritating hygiene products

Lifestyle and hygiene measures

  • Wear cotton underwear, avoid synthetic materials
  • No excessive intimate hygiene or perfumed products
  • Use of condoms for infection prevention with changing partners
  • Gynecological routine check-ups at least once a year

Continuous mucosal care

After successful acute therapy, regular use of CANNEFF® suppositories can help prevent relapses. CANNEFF® stabilizes the mucosal barrier while acting anti-inflammatory. Women in perimenopause or with sensitive mucosa especially benefit from this regenerative, hormone-free adjunct therapy.

When is partner treatment required?

Partner treatment is a central aspect in the therapy of infectious cervicitis, especially in sexually transmitted infections (STIs). The goal is to prevent reinfections and ensure complete healing in both partners. An untreated infection in the partner can not only lead to repeated relapses in the patient but also promote the spread within the population.

Treatment of cervicitis HPV

When is partner treatment absolutely necessary?

Partner treatment is indicated when the following pathogens have been detected in the patient:

Pathogen

Is partner treatment recommended?

Justification

Chlamydia trachomatis

Yes

High transmission rate, often asymptomatic

Neisseria gonorrhoeae

Yes

Highly infectious, high reinfection rate

Trichomonas vaginalis

Yes

Often asymptomatic in men, high relapse risk

Mycoplasma genitalium

Yes

Prolonged course, high relapse potential

Herpes simplex virus

Only with symptoms

Reactivation possible, transmission during activity

Candida albicans

Usually not necessary

Low transmission probability

Bacterial vaginosis/dysbiosis

No

No STI, but hygiene measures advisable

How is partner treatment carried out?

  • In bacterial infections, treatment is usually with the same antibiotics (e.g. azithromycin for chlamydia).
  • Partners should be treated even if symptoms are absent.
  • During treatment and for at least seven days after therapy start, sexual intercourse should be avoided.
  • Medical consultation of the partner – including urological – is advisable to exclude co-infections.

When is partner treatment not necessary?

  • If no sexually transmitted cause is detectable (e.g. in hormonally induced or irritative cervicitis).
  • If the inflammation was triggered by mechanical irritation or mucosal atrophy.
  • In fungal infections, partner treatment is only useful if both partners show symptoms or the infection recurs.

Importance of partner diagnostics

Especially in repeated or chronic cases, an undetected infection in the partner can be the key to understanding the disease. Targeted partner diagnostics are therefore of great importance not only therapeutically but also preventively.

What should be considered after treatment?

After treating cervicitis, it is important to ensure complete healing of the mucosa and to avoid relapses. The following measures are advisable:

  • Follow-up check at the gynecologist about 4 weeks after therapy completion, especially if pathogens were previously detected.
  • No sexual intercourse for at least 7 days after the end of treatment (for STIs) to avoid reinfections.
  • Partner treatment to be carried out with the partner if sexually transmitted pathogens have been diagnosed.
  • mucous membrane care support – e.g. with CANNEFF® vaginal suppositories for regeneration and moisture supply.
  • Avoid irritants, e.g. aggressive intimate care products, tight clothing, or frequent mechanical stress.
  • Gynecological check-up attend regularly – especially with chronic or recurring complaints.

These measures help restore the mucosal barrier, minimize the risk of relapse, and stabilize vaginal health in the long term.

Back to the blog
Philip Schmiedhofer, MSc

Philip Schmiedhofer, MSc

Medical Technician & Neuroscientist

Philip is the managing director and co-founder of cannmedic GmbH. With a degree in medical engineering and molecular biology, specializing in neuroscience and focusing on cannabinoids, he is recognized as an expert in the application of cannabinoids in medicine. As a medical device consultant, he leads the sales of cannmedic and offers specialized advice to medical professionals. His expertise includes the development and sales of cannabinoid-based products. In the field of research, he participates in significant basic research at the Center for Brain Research at the Medical University of Vienna. As co-founder and current managing director of cannhelp GmbH, a pioneer in the CBD sector, he has many years of entrepreneurial experience. Furthermore, he maintains an extensive network in the industry and advises internationally operating companies in the field of medical cannabinoids.